AtriCure, Inc. (ATRC)
NASDAQ: ATRC · Real-Time Price · USD
35.09
-1.61 (-4.39%)
Aug 14, 2025, 11:52 AM - Market open
AtriCure Employees
AtriCure had 1,300 employees as of December 31, 2024. The number of employees increased by 100 or 8.33% compared to the previous year.
Employees
1,300
Change (1Y)
100
Growth (1Y)
8.33%
Revenue / Employee
$384,574
Profits / Employee
-$27,968
Market Cap
1.74B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1,300 | 100 | 8.33% |
| Dec 31, 2023 | 1,200 | 150 | 14.29% |
| Dec 31, 2022 | 1,050 | 175 | 20.00% |
| Dec 31, 2021 | 875 | 125 | 16.67% |
| Dec 31, 2020 | 750 | 20 | 2.74% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ATRC News
- 15 days ago - AtriCure, Inc. (ATRC) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 15 days ago - AtriCure Reports Second Quarter 2025 Financial Results; Raises Financial Outlook for 2025 - Business Wire
- 17 days ago - AtriCure to Participate in the Canaccord Genuity 45th Annual Growth Conference - Business Wire
- 4 weeks ago - AtriCure Completes Enrollment in LeAAPS Clinical Trial for Stroke Prevention - Business Wire
- 5 weeks ago - AtriCure to Announce Second Quarter 2025 Financial Results - Business Wire
- 2 months ago - AtriCure to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference - Business Wire
- 3 months ago - AtriCure, Inc. (ATRC) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - AtriCure Reports First Quarter 2025 Financial Results - Business Wire